Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Jan 15, 2005 (Vol. 25, No. 2)

Bioinformatics Links Directory

URL:www.bioinformatics.ubc.ca/resources/links_directory
  • Organization, relevance of links
  • None
If you were to divide bioinformatics up in to broad categories, how would you do it? The folks at the Bioinformatics Links Directory segment the field into ten interesting groups, including some you might expect (DNA, RNA, Protein, Sequence Comparison) and others you might not expect (Model Organisms, Expression, Other Molecules). One of the categories (at press time) didn’t even have any entries. Ooops! That’s about all there is to fault, though, at Bioinformatics Links Directory’s excellent collection of links. It gained entry into my browser’s bookmarks just a few seconds after I scanned its contents. With excellent organization, good descriptions, and a very relevant set of links, the Bioinformatics Links Directory is a must for anyone interested in the field.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »